000 01369 a2200433 4500
005 20250514224810.0
264 0 _c20050720
008 200507s 0 0 eng d
022 _a0928-1231
024 7 _a10.1007/s11096-005-4731-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _avan Hulten, Rolf
245 0 0 _aInitial benzodiazepine use and improved health-related quality of life.
_h[electronic resource]
260 _bPharmacy world & science : PWS
_cFeb 2005
300 _a41-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnti-Anxiety Agents
_xadministration & dosage
650 0 4 _aBenzodiazepines
_xadministration & dosage
650 0 4 _aDrug Administration Schedule
650 0 4 _aDrug Utilization
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHealth Status
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMental Health
650 0 4 _aMiddle Aged
650 0 4 _aNetherlands
650 0 4 _aQuality of Life
650 0 4 _aSex Factors
650 0 4 _aSocioeconomic Factors
700 1 _aTeeuw, Bart
700 1 _aBakker, Albert
700 1 _aLeufkens, Hubert G
773 0 _tPharmacy world & science : PWS
_gvol. 27
_gno. 1
_gp. 41-6
856 4 0 _uhttps://doi.org/10.1007/s11096-005-4731-0
_zAvailable from publisher's website
999 _c15528527
_d15528527